Showing results (21-30 of 117) with videos related to
Sort By:
Pageof 12
Journal of Anatomy|September 3, 2010
Stereological assessment of pancreatic beta-cell mass development in male Zucker Diabetic Fatty (ZDF) rats: correlation with pancreatic beta-cell functionSarah Juel Paulsen, Niels Vrang, Leif Kongskov Larsen, et al.Brain Research|February 20, 2003
Hypothalamic cocaine-amphetamine regulated transcript (CART) is regulated by glucocorticoidsNiels Vrang, Philip J Larsen, Mads Tang-Christensen, et al.American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|August 18, 2006
PYY(3-36) reduces food intake and body weight and improves insulin sensitivity in rodent models of diet-induced obesityNiels Vrang, Andreas Nygaard Madsen, Mads Tang-Christensen, et al.Peptides|April 22, 2015
Neuromedin U inhibits food intake partly by inhibiting gastric emptyingLouise S Dalbøge, Søren L Pedersen, Thomas Secher, et al.Schizophrenia Research|June 27, 2008
The once-daily human GLP-1 analog, liraglutide, reduces olanzapine-induced weight gain and glucose intoleranceKirsten Lykkegaard, Philip J Larsen, Niels Vrang, et al.Endocrinology|July 3, 2004
Central administration of ghrelin and agouti-related protein (83-132) increases food intake and decreases spontaneous locomotor activity in ratsMads Tang-Christensen, Niels Vrang, Sylvia Ortmann, et al.Journal of Neuroscience Methods|October 29, 2008
Gene expression profiling of individual hypothalamic nuclei from single animals using laser capture microdissection and microarraysSarah Juel Paulsen, Leif Kongskov Larsen, Jacob Jelsing, et al.Molecular Metabolism|April 13, 2016
Alterations in hypothalamic gene expression following Roux-en-Y gastric bypassPernille Barkholt, Philip J Pedersen, Anders Hay-Schmidt, et al.European Journal of Pharmacology|August 28, 2014
The DPP-IV inhibitor linagliptin and GLP-1 induce synergistic effects on body weight loss and appetite suppression in the diet-induced obese ratHenrik H Hansen, Gitte Hansen, Sarah Paulsen, et al.Drug Discovery Today|July 9, 2017
Mouse models of nonalcoholic steatohepatitis in preclinical drug developmentHenrik H Hansen, Michael Feigh, Sanne S Veidal, et al.Pageof 12